ArticleTransplantation and cellular therapy2022

Lenalidomide-Based Maintenance after Autologous Hematopoietic Stem Cell Transplantation for Patients with High-Risk Multiple Myeloma.

Oren Pasvolsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.